Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00250172 · ClinicalTrials.gov registry record · Phase 1
PET Whole Body Biodistribution and Test Retest Bain Imaging Studies Using a Phosphodiesterase 4 Inhibitor (R)-[11C]Rolipram
A Phase 1 study, sponsored by National Institute of Mental Health (NIMH).
- Completed
- Registry status
- Phase 1
- Development phase
- 26
- Enrollment target
NCT00250172 is a Phase 1 study that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 26 participants.
The verdict
NCT00250172, a Phase 1 study, has completed, sponsored by National Institute of Mental Health (NIMH).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 26 participants
- Enrollment target
Study Summary
The purpose of this study is to measure a particular protein in the brain called the phosphodiesterase by using the imaging techniques of positron emission tomography (PET) and magnetic resonance imaging (MRI). ...
Interventions
- DRUG [C-11](R)-rolipram
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2005-10-31 |
| Est. Completion | 2009-02-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00250172
The ClinicalTrials.gov registry entry for NCT00250172 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Mental Health (NIMH), which has 343 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which [C-11](R)-rolipram is the first listed.
NCT00250172 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00250172 about?
NCT00250172 is a clinical study titled "PET Whole Body Biodistribution and Test Retest Bain Imaging Studies Using a Phosphodiesterase 4 Inhibitor (R)-[11C]Rolipram". The purpose of this study is to measure a particular protein in the brain called the phosphodiesterase by using the imaging techniques of positron emission tomography (PET) and magnetic resonance imaging (MRI). ...
What is the current status of trial NCT00250172?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 26 participants. The study started on 2005-10-31. Estimated completion is 2009-02-05.
What interventions are being tested in trial NCT00250172?
The interventions under investigation include: [C-11](R)-rolipram (DRUG).
Who is sponsoring clinical trial NCT00250172?
This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.